BioCentury | Jun 1, 2015
Company News

Astellas musculoskeletal, ophthalmic news

...posterior eye disorders, including retinitis pigmentosa, through a collaboration with Harvard Medical School (Boston, Mass.). ASP8232...
BioCentury | May 28, 2015
Company News

Astellas adds muscle disease, ophthalmology TAs

...eye disorders, including retinitis pigmentosa, through a collaboration with Harvard Medical School . It said ASP8232...
BioCentury | Feb 11, 2013
Clinical News

ASP8232: Phase I started

...it began a Phase I trial of ASP8232. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Product: ASP8232...
Items per page:
1 - 3 of 3